Key result
Prompt revascularization fails to improve 5-year survival or major cardiovascular events over medical therapy.
Why the study?
Does prompt revascularization compared to intensive medical therapy alone, or insulin-sensitization compared to insulin-provision therapy, reduce the rate of death and major cardiovascular events in patients with type 2 diabetes and stable ischemic heart disease?
RCT (n=2,368)
Stratified factorial randomization (revascularization vs medical therapy, and insulin-sensitization vs insulin-provision, stratified by intended PCI or CABG)
Does prompt revascularization compared to intensive medical therapy alone, or insulin-sensitization compared to insulin-provision therapy, reduce the rate of death and major cardiovascular events in patients with type 2 diabetes and stable ischemic heart disease?
Answers are grounded in this paper and cite their sources.
In patients with type 2 diabetes and stable ischemic heart disease, overall 5-year mortality and major cardiovascular events did not differ significantly between prompt revascularization and intensive medical therapy alone, or between insulin sensitization and insulin provision, although CABG reduced major cardiovascular events compared to medical therapy in its stratum.
BACKGROUND: Optimal treatment for patients with both type 2 diabetes mellitus and stable ischemic heart disease has not been established. METHODS: We randomly assigned 2368 patients with both type 2 diabetes and heart disease to undergo either prompt revascularization with intensive medical therapy or intensive medical therapy alone and to undergo either insulin-sensitization or insulin-provision therapy. Primary end points were the rate of death and a composite of death, myocardial infarction, or stroke (major cardiovascular events). Randomization was stratified according to the choice of percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) as the more appropriate intervention. RESULTS: At 5 years, rates of survival did not differ significantly between the revascularization group (88.3%) and the medical-therapy group (87.8%, P=0.97) or between the insulin-sensitization group (88.2%) and the insulin-provision group (87.9%, P=0.89). The rates of freedom from major cardiovascular events also did not differ significantly among the groups: 77.2% in the revascularization group and 75.9% in the medical-treatment group (P=0.70) and 77.7% in the insulin-sensitization group and 75.4% in the insulin-provision group (P=0.13). In the PCI stratum, there was no significant difference in primary end points between the revascularization group and the medical-therapy group. In the CABG stratum, the rate of major cardiovascular events was significantly lower in the revascularization group (22.4%) than in the medical-therapy group (30.5%, P=0.01; P=0.002 for interaction between stratum and study group). Adverse events and serious adverse events were generally similar among the groups, although severe hypoglycemia was more frequent in the insulin-provision group (9.2%) than in the insulin-sensitization group (5.9%, P=0.003). CONCLUSIONS: Overall, there was no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy or between strategies of insulin sensitization and insulin provision. (ClinicalTrials.gov number, NCT00006305.)
No takes yet. Share an insight, caveat, or question.
A 2009 study conducted an RCT in Type 2 diabetes mellitus and stable ischemic heart disease (coronary artery disease) (n=2,368). Prompt revascularization (PCI or CABG) with intensive medical therapy; and insulin-sensitization therapy vs. Intensive medical therapy alone; and insulin-provision therapy was evaluated on 5-year rate of survival (rate of death) and freedom from major cardiovascular events (composite of death, myocardial infarction, or stroke) (p=0.97). Prompt revascularization vs medical therapy and insulin sensitization vs provision did not differ in 5-year survival or major cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: